Home›Search›Molecular Cancer Therapeutics

Molecular Cancer Therapeutics

American Association for Cancer Research Inc. · United States · Est. 1960

ISSN1535-7163eISSN1538-8514

SJR Q1✓ WOS SCIE✓ Scopus / SJR

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 25% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

2.392

H-Indexi

216

SNIPi

1.138

Total Worksi

12,688

Total Citationsi

366,577

2yr Mean Citednessi

1.51

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

Subject areas: Oncology; Cancer Research.

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published1960

FrequencyMonthly

StatusActive (last: 2026)

Total Publications12,688

Publisher OrgAmerican Association for Cancer Research

Visit Journal Website

Submission Info

Peer ReviewSingle-blind peer review

OA LicenseCC BY 4.0

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

8/11 · 73%

✅

Do you know the journal / publisher?

American Association for Cancer Research Inc.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1535-7163 / 1538-8514

✅

Indexed in a trusted database?

WoS, Scopus

✅

Peer review process documented?

Single-blind peer review

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

✅

Plagiarism detection in place?

Yes

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

724

11k

2019

224

7.9k

2020

524

7.9k

2021

170

3.7k

2022

720

2.6k

2023

365

1.7k

2024

612

582

2025

127

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cancer ResearchQ1

OncologyQ1

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Cancer ResearchOncology

Research Topics (OpenAlex)

Cancer, Hypoxia, and MetabolismCancer-related Molecular PathwaysMonoclonal and Polyclonal Antibodies ResearchCancer Genomics and DiagnosticsHER2/EGFR in Cancer ResearchLung Cancer Treatments and MutationsCancer Research and TreatmentsPI3K/AKT/mTOR signaling in cancerUbiquitin and proteasome pathwaysProtein Degradation and Inhibitors

Frequently asked questions about Molecular Cancer Therapeutics

Is Molecular Cancer Therapeutics a predatory journal?

PubScope has no integrity flags on record for Molecular Cancer Therapeutics: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Molecular Cancer Therapeutics?

Molecular Cancer Therapeutics is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.51.

Is Molecular Cancer Therapeutics indexed in Scopus and Web of Science?

Molecular Cancer Therapeutics is indexed in Web of Science, Scopus.

What is the aims and scope of Molecular Cancer Therapeutics?